Search Results
Found 6,153 results for "cps products"
Safety Alert
Health Canada
Health CanadaArchived - Health Canada Advises Consumers Not to Ingest Teas or Health Products Containing Star Anise Unless it Is Identified as Chinese Star Anise
Communications and Public Affairs Branch
Health CanadaGeneral Alert
Archived - Health Canada Advises Consumers Not to Ingest Teas or Health Products Containing Star Anise Unless it Is Identified as Chinese Star Anise
Jun 29, 2004Communications and Public Affairs Branch
Safety AlertHealth Canada
Health CanadaArchived – ARAVA (Leflunomide) and Lung Inflammation Causing Difficulty Breathing – For the Public
Marketed health products
Health CanadaGeneral Alert
Archived – ARAVA (Leflunomide) and Lung Inflammation Causing Difficulty Breathing – For the Public
Product safety
Jun 24, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaARAVA (Leflunomide) and Interstitial Lung Disease – For Health Professionals
Marketed health products
Health CanadaGeneral Alert
ARAVA (Leflunomide) and Interstitial Lung Disease – For Health Professionals
Product safety
Jun 24, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaPossibility of Sensitization to CIDEX OPA Solution with Repeated Exposure – For Health Professionals
Marketed health products
Health CanadaGeneral Alert
Possibility of Sensitization to CIDEX OPA Solution with Repeated Exposure – For Health Professionals
Product safety
Jun 24, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaHealth Canada releases important information on the dispensation of CLOZAPINE products in Canada - For Health Professionals
Marketed health products
Health CanadaGeneral Alert
Health Canada releases important information on the dispensation of CLOZAPINE products in Canada - For Health Professionals
Jun 23, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaHealth Canada Releases Important Information on the Dispensation of CLOZAPINE Products in Canada – Notice to Hospitals
Marketed health products
Health CanadaGeneral Alert
Health Canada Releases Important Information on the Dispensation of CLOZAPINE Products in Canada – Notice to Hospitals
Product safety
Jun 23, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Important Safety Information Regarding the Association Between CRESTOR (Rosuvastatin) and Rhabdomyolysis
Marketed health products
Health CanadaGeneral Alert
Archived – Important Safety Information Regarding the Association Between CRESTOR (Rosuvastatin) and Rhabdomyolysis
Product safety
Jun 22, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Health Canada Endorsed Important Safety Information on PRE-PEN® (Benzylpenicilloyl Polylysine Injection USP) DIN: 00328693
Marketed health products
Health CanadaGeneral Alert
Archived – Health Canada Endorsed Important Safety Information on PRE-PEN® (Benzylpenicilloyl Polylysine Injection USP) DIN: 00328693
Product safety
Jun 18, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Important Safety Information on Hemodialysis Units and Blood Tubing Sets Incorporating a Transducer Protector – Notice to Hospitals
Marketed health products
Health CanadaGeneral Alert
Archived – Important Safety Information on Hemodialysis Units and Blood Tubing Sets Incorporating a Transducer Protector – Notice to Hospitals
Product safety
Jun 11, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Important Drug Safety Information for WELLBUTRIN® SR and ZYBAN® (Bupropion HCI): Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-Harm
Marketed health products
Health CanadaGeneral Alert
Archived – Important Drug Safety Information for WELLBUTRIN® SR and ZYBAN® (Bupropion HCI): Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-Harm
Product safety
Jun 10, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Bronchial Problems Associated with Rapamune® (Sirolimus) – For the Public
Marketed health products
Health CanadaGeneral Alert
Archived – Bronchial Problems Associated with Rapamune® (Sirolimus) – For the Public
Product safety
Jun 5, 2004Marketed health products
Safety Alert
CPSC
CPSCCPSC, Electrolux Home Products Announce Recall of Air Conditioning/Heating Units
Electrolux Home Products Inc., of Cleveland, Ohio
CPSCGeneral Alert
CPSC, Electrolux Home Products Announce Recall of Air Conditioning/Heating Units
The heating coil in the units can be damaged during assembly, causing an electrical short and overheating, which poses a fire hazard to consumers.
Jun 3, 2004Electrolux Home Products Inc., of Cleveland, Ohio
Safety AlertHealth Canada
Health CanadaImportant Drug Safety Information for CELEXA: Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-Harm
Marketed health products
Health CanadaGeneral Alert
Important Drug Safety Information for CELEXA: Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-Harm
Product safety
Jun 2, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Important Drug Safety Information for ZOLOFT: Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-Harm
Marketed health products
Health CanadaGeneral Alert
Archived – Important Drug Safety Information for ZOLOFT: Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-Harm
Product safety
Jun 2, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Important Drug Safety Information for Paroxetine: Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-Harm
Marketed health products
Health CanadaGeneral Alert
Archived – Important Drug Safety Information for Paroxetine: Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-Harm
Product safety
Jun 2, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Important Drug Safety Information for Prozac: Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-Harm
Marketed health products
Health CanadaGeneral Alert
Archived – Important Drug Safety Information for Prozac: Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-Harm
Product safety
Jun 2, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaImportant Drug Safety Information for REMERON RDTM/REMERON® : Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-Harm
Marketed health products
Health CanadaGeneral Alert
Important Drug Safety Information for REMERON RDTM/REMERON® : Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-Harm
Product safety
Jun 2, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Important Drug Safety Information for LUVOX: Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-Harm
Marketed health products
Health CanadaGeneral Alert
Archived – Important Drug Safety Information for LUVOX: Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-Harm
Product safety
Jun 2, 2004Marketed health products
Safety AlertCPSC
CPSCCPSC, Backyard Products Announce Recall of Swings
Backyard Products™, of Collingwood, Ontario, Canada
CPSCGeneral Alert
CPSC, Backyard Products Announce Recall of Swings
Chains on the swing can detach during use, and cause the child to fall to the ground and possibly suffer injuries.
May 27, 2004Backyard Products™, of Collingwood, Ontario, Canada
Safety AlertCPSC
CPSCCPSC, A. O. Smith Co. Announce Recall of Spas
Coast Mountain® Spas, of Langley, British Columbia, Canada, A. O. Smith Electrical Products Company, of Tipp City, Ohio
CPSCGeneral Alert
CPSC, A. O. Smith Co. Announce Recall of Spas
The motor in the circulating pump can overheat, posing a fire hazard to consumers.
May 27, 2004Coast Mountain® Spas, of Langley, British Columbia, Canada, A. O. Smith Electrical Products Company, of Tipp City, Ohio
Safety AlertCPSC
CPSCCPSC, Avon Products Inc. Announce Recall to Repair Snowman Nightlight Diffuser
Cosmos Gifts Corporation, of Dallas, Texas
CPSCGeneral Alert
CPSC, Avon Products Inc. Announce Recall to Repair Snowman Nightlight Diffuser
The scented oil can drip, causing the nightlight base to crack or break, exposing electrical wire or metal parts inside the nightlight, thus causing a potential shock hazard. There is also a risk of cuts, if the nightlight breaks.
May 19, 2004Cosmos Gifts Corporation, of Dallas, Texas
Safety AlertHealth Canada
Health CanadaArchived – Important New Safety Information on ORTHOCLONE OKT*3 (Muromonab-CD3) – For the Public
Marketed health products
Health CanadaGeneral Alert
Archived – Important New Safety Information on ORTHOCLONE OKT*3 (Muromonab-CD3) – For the Public
Product safety
May 17, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Serious Adverse Reactions in Pediatric Patients Treated with ORTHOCLONE OKT*3 (muromonab-CD3) – Notice to Hospitals
Marketed health products
Health CanadaGeneral Alert
Archived – Serious Adverse Reactions in Pediatric Patients Treated with ORTHOCLONE OKT*3 (muromonab-CD3) – Notice to Hospitals
Product safety
May 13, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Emerging Safety Information: Diarrhea and Ischemic Colitis in Patients Using ZELNORM (Tegaserod Hydrogen Maleate) – Novartis Pharmaceuticals Canada Inc. – For the Public
Marketed health products
Health CanadaGeneral Alert
Archived – Emerging Safety Information: Diarrhea and Ischemic Colitis in Patients Using ZELNORM (Tegaserod Hydrogen Maleate) – Novartis Pharmaceuticals Canada Inc. – For the Public
Product safety
May 13, 2004Marketed health products